3rd Quarter - Report

EMD SERONO, INC. for EMD SERONO INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$870,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 20, 2023 $870,000 Replaced
3rd Quarter - Amendment Jan 22, 2024 $890,000 Yes

What was lobbied

13 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

General discussions related to Biopharmaceutical innovation and patent policy issues

LobbyistCovered position, as disclosed
THOMAS BORCK —
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Defense DEF

H.R. 2760: National Defense Authorization Act for Fiscal Year 2024; provisions related to Military access to infertility care S. 2226: National Defense Authorization Act for Fiscal Year 2024; provisions related to Military access to infertility care

LobbyistCovered position, as disclosed
THOMAS BORCK —
MALLORI ANNE MERANDINO —
DAVID NICHOLS New None

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: S. 2226 (118th), H.R. 2760 (118th)

Taxation/Internal Revenue Code TAX

H.R. 2673: American Innovation and R&D Competitiveness Act of 2023; provisions related to R & D Tax Amortization S. 866: American Innovation and Jobs Act; provisions related to R & D Tax Amortization

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —
DAVID NICHOLS New None
PAUL JEFFREY TREADGOLD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2673 (118th), S. 866 (118th)

Budget/Appropriations BUD

General discussions regarding Healthcare issues related to FY 2024 President's budget request General discussions regarding Healthcare issues related to FY 2024 budget resolution, debt limit General discussions regarding Veteran infertility benefits in MilCon/VA appropriations bill

LobbyistCovered position, as disclosed
THOMAS BORCK —
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

P.L. 117-167: Supreme Court Security Funding Act of 2022 (H.R. 4346 -CHIPS and Science Act of 2022): discussions regarding ensuring both aspects of the CHIPS and Science Act of 2022 are funded through appropriations process with sufficient guardrails on use of funds

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —
DAVID NICHOLS New None
PAUL JEFFREY TREADGOLD —

Contacted: SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4346 (118th)

Family issues/Abortion/Adoption FAM

HR 544: Veterans Infertility Treatment Act of 2023; all provisions of the bill

LobbyistCovered position, as disclosed
MALLORI ANNE MERANDINO —

Contacted: White House Office; Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 544 (118th)

Veterans VET

General discussions regarding Veteran infertility benefits in MilCon/VA appropriations bill General discussions regarding Veteran access to infertility care

LobbyistCovered position, as disclosed
THOMAS BORCK —
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office; Veterans Affairs, Dept of (VA)

Trade (domestic/foreign) TRD

H.R. 3136: National Critical Capabilities Defense Act of 2023; provisions related to China and outbound investment review mechanism

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —
DAVID NICHOLS New None
PAUL JEFFREY TREADGOLD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3136 (118th)

Health Issues HCR

HR 544: Veterans Infertility Treatment Act of 2023; all provisions of the bill HR 547: Better Care Better Jobs Act; all provisions of the bill HR 830:Help Ensure Lower Patient (HELP) Copays Act; all provisions of the bill HR 2534: Preserving Rules Ordered for The Entities Covered Through 340B Act of 2023(PROTECT 340B Act); all provisions of the bill H.R. 2880: Protecting Patients Against PBM Abuses Act; all provisions of the bill H.R. 5378: Lower Costs, More Transparency Act; all provisions of the bill S 100: Better Care Better Jobs Act; all provisions of the bill S. 1339: Pharmacy Benefit Manager Reform Act; all provisions of the bill S. 1375: Help Ensure Lower Patient (HELP) Copays Act; all provisions of the bill S. 1542: Delinking Revenue from Unfair Gouging (DRUG) Act; all provisions of the bill S. 1967: Patients Before Middlemen (PBM) Act; all provisions of the bill P.L. 117-169: Inflation Reduction Act of 2022; implementation of Drug pricing provisions General discussions related to 340B Drug Pricing Program policy issues General discussions related to Pharmacy Benefit Manager policy issues General discussions related to Healthcare supply chain policy issues General discussions related to Drug cost and pricing policy issues General discussions related to caregiving support and awareness policy issues General discussions related to the Cancer Moonshot Initiative and the Advanced Research Projects Agency for Health (ARPA-H)

LobbyistCovered position, as disclosed
THOMAS BORCK —
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 547 (118th), S. 1542 (118th), H.R. 5378 (118th), S. 1967 (118th), S. 1339 (118th), S. 1375 (118th), H.R. 544 (118th), H.R. 2534 (118th), H.R. 2880 (118th), H.R. 830 (118th)

Medicare/Medicaid MMM

H.R. 2880: Protecting Patients Against PBM Abuses Act; all provisions of the bill H.R. 5378: Lower Costs, More Transparency Act; all provisions of the bill S. 1967: Patients Before Middlemen (PBM) Act; all provisions of the bill P.L. 117-169: Inflation Reduction Act of 2022; implementation of Parts B & D provisions General discussions related to Drug cost and pricing policy issues

LobbyistCovered position, as disclosed
THOMAS BORCK —
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: S. 1967 (118th), H.R. 5378 (118th), H.R. 2880 (118th)

Pharmacy PHA

HR 830:Help Ensure Lower Patient (HELP) Copays Act; all provisions of the bill H.R. 5378: Lower Costs, More Transparency Act; all provisions of the bill S. 1339: Pharmacy Benefit Manager Reform Act; all provisions of the bill S. 1375: Help Ensure Lower Patient (HELP) Copays Act; all provisions of the bill S. 1542: Delinking Revenue from Unfair Gouging (DRUG) Act; all provisions of the bill General discussions related to Drug cost and pricing policy issues General discussions related to Healthcare supply chain policy issues

LobbyistCovered position, as disclosed
THOMAS BORCK —
MALLORI ANNE MERANDINO —
TERRI STEWART —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 830 (118th), H.R. 5378 (118th), S. 1339 (118th), S. 1542 (118th), S. 1375 (118th)

Environment/Superfund ENV

Discussions related to the Toxic Substances Control Act, PFAS, and the semiconductor industry

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —
DAVID NICHOLS New None
PAUL JEFFREY TREADGOLD —

Contacted: Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA)

Foreign Relations FOR

Discussions related to United States - China relations, and export controls

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) —
DAVID NICHOLS New None
PAUL JEFFREY TREADGOLD —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.